If you need more lookups,
subscriptions start at $34 USD/month.
Lu Chen Location
Irvine, CA, US
Lu Chen Work
VP of Product Development and CMC @ (August 2022 - Present)
Head of Product Development and CMC @ (October 2021 - September 2022)
Director of Product Development and CMC @ (January 2021 - October 2021)
Principal Scientist, Cell Therapy Process Development @ (August 2019 - January 2021)
Sr. Scientist II @ (April 2019 - August 2019)
Sr. Scientist I @ (October 2017 - April 2019)
Scientist @ (April 2016 - October 2017)
Scientist @ (August 2015 - January 2016)
Assistant Project Scientist @ (May 2014 - July 2015)
Research Fellow @ (September 2010 - April 2014)
Research Fellow @ (May 2009 - September 2010)
Lu Chen Education
Albert Einstein College of Medicine
Ph.D. (Biomedical Sciences)
2003-2009
University of Science and Technology of China
B.S (Life Sciences)
1995-2000
Harbin Normal University High School 1992-1995
Lu Chen Skills
Good Laboratory Practice Glp
Cell Biology
ELISA
Western Blotting
In Vivo
Animal Models
Autoimmune Diseases
Confocal Microscopy
Biotechnology
Cell
PCR
Immunology
Life Sciences
Cell Culture
Medical Devices
Molecular Biology
Histology
Immunohistochemistry
ELISPOT
In Vitro
Stem Cell Transplant
Cell Based Assays
Molecular Cloning
Genetics
Biochemistry
Neurodegenerative Disease
Flow Cytometry
Regenerative Medicine
Fluorescence Microscopy
Embryonic Stem Cells
Protein Chemistry
IND
Stem Cells
Good Laboratory Practice
Lu Chen Summary
Lu Chen, based in Irvine, CA, US, is currently a VP of Product Development and CMC at Renovaro Biosciences Inc.. Lu Chen brings experience from previous roles at Enochian BioSciences Inc, Atara Biotherapeutics and Irvine Scientific. Lu Chen holds a 2003 - 2009 Ph.D. in Biomedical Sciences @ Albert Einstein College of Medicine. With a robust skill set that includes Good Laboratory Practice Glp, Cell Biology, ELISA, Western Blotting, In Vivo and more. Lu Chen has 5 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Lu Chen?
Find contact details for 700 million professionals.